$11.11
$-0.17 (-1.51%)
End-of-day quote: 05/17/2024
NasdaqGS:DVAX
Dynavax Technologies Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.72 | $87.82 | 0.00% | 14 | $84.36B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.93B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| BNTX | BioNTech | NasdaqGS | Outperform | $90.61 | $123.75 | 0.00% | 3 | $21.84B |
| NVAX | Novavax | NasdaqGS | Outperform | $13.01 | $23.25 | 0.00% | 4 | $623.13M |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.63 | $6.00 | 0.00% | 0 | $18.27M |
